ERIN BALES: Open Payments
NPI 1437714508 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 66 payments from 31 companies in 2025. Trend: 2023 $440 · 2024 $1,068 · 2025 $1,170
Food & beverage: $1,111Education: $59
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 14 | $160 |
| ABBVIE INC. | 6 | $112 |
| Janssen Biotech, Inc. | 5 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $58 |
| TAIHO ONCOLOGY, INC. | 3 | $54 |
| SOBI, INC | 2 | $42 |
| PharmaEssentia USA Corporation | 2 | $40 |
| PFIZER INC. | 2 | $38 |
Products named: Enhertu, ELAHERE, RYBREVANT, LONSURF, BESREMI, XTANDI, DATROWAY, NERLYNX.
Industry payments across ND — which companies pay providers there.
